TNPH — Hanyuan Biotech International Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for Hanyuan Biotech International, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2005 December 31st	2006 December 31st	2007 December 31st
Period Length:	12 M	12 M	12 M
Source:	10KSB	10KSB	10KSB
Standards:	USG	USG	USG
Status:	Final	Final	Final
Revenue
Total Revenue	3.52	7.08	10.7
Cost of Revenue
Gross Profit	2.25	4.59	7.3
Selling / General / Administrative Expenses
Depreciation and Amortization
Operating Interest Expense / Income
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	2.24	5.28	6.95
Operating Profit	1.28	1.8	3.7
Net Income Before Taxes	1.28	1.8	3.7
Provision for Income Taxes
Net Income After Taxes	1.06	1.52	3.14
Minority Interest
Net Income Before Extraordinary Items
Net Income	1.06	1.52	3.14
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	1.06	1.52	3.14
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.076	0.109	0.225
Dividends per Share